Evaluation of prenatal diagnosis for Turner syndrome in Hanoi obstetric and gynaecology hospital

Thúy Linh Đinh1, Thế Vương Phạm1, Trọng Hưng Mai1,
1 Bệnh viện Phụ sản Hà Nội

Main Article Content

Abstract

Background & Objective: Turner syndrome  is the most common sex chromosome abnormality in female (1 in 2500 female live births) and is caused by a complete or partial X monosomy in some or all cells. Turner syndrome  is characterized by short stature, web neck anomaly, and gonadal dysgenesis. The study aims to illustrate the chromosomal abnormalities in fetuses diagnosed with Turner syndrome and assess the correlations between karyotyping results and prenatal ultrasound findings. Methods: A retrospective descriptive study was conducted on 36 fetuses with Turner syndrome by collecting the karyotype (the G-banding) from amniotic fluid, and analyzed the correlation between these karyotyping results and the respective prenatal ultrasound findings of the fetuses in the first and second trimesters of pregnancy. Results: Among the 36 Turner syndrome fetuses, 38.9% of the cases were non-mosaic 45,X, 27.8% were mosaic 45,X with 46,XX or 47,XXX cell lines; 16.7% were mosaic 45,X with 46,XY cell lines; 13.9% had structural abnormalities of the X chromosome; and 2.7% had unbalanced translocations between the X chromosome and an autosome The non-mosaic 45,X cases showed more abnormal ultrasound findings and more severe phenotypic abnormalities compared to mosaic Turner Syndrome or those with structural chromosomal abberations. Conclusions: The current data suggests the increased pre- and post-natal prognostics accuracy for fetuses with Turner syndrome through the combined use of obstetric ultrasonography and cytogenetic analyses

Article Details

References

1. Baena N, Vigan CD, Cariati E, et al. Turner syndrome: Evaluation of prenatal diagnosis in 19 European. Am J Med Genet A. 2004; 129A(1):16-20.
2. Kaisenberg CS, Wilting J, Dörk T, et al. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner’s syndrome: Comparison with trisomies and controls. Mol Hum Reprod. 2010; 16(10):778-789.
3. Csaba P, Artur B, Gabor M, et al. Prenatal diagnosis of turner syndrome: Report on 69 cases. J Ultrasound Med. 2006; 25(6):711-717.
4. Louise K, Ricardo PD, Debbie N, et al. Non-invasive prenatal testing for sex chromosome aneuploidy in routine clinical practice. Fetal Diagn Ther. 2018; 44(2):85-90.
5. Bing H, Maya T, Sucheta B, et al. Prenatal diagnosis of 45,X and 45,X mosaicism: The need for thorough cytogenetic and clinical evaluations. Prenat Diagn. 2002; 22(2):105-110.
6. Allybocus ZA. Clinical significance of ultrasonography markers in prenatal diagnosis of turner syndrome in fetuses-90 cases reports. J Radiol Clin Imaging. 2019:7-15.
7. Claus HG, Niels HA, Gerard SC, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177(3):G1-G70.
8. Sybert VP. Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet. 2002; 39(3):217-220.